CCND1 and neoplasm: We show that exogenous wild-type β−catenin increases CRT, CCND1 promoter activity and tumor cell survival in HCT116 and in HepG2 cells carrying heterozygous β−catenin ΔS45 and Δ25-140, respectively, thus lacking key phosphorylable residues in one of the alleles.